Xiao M, Oppenlander B K, Plunkett J M, Dooley D C
Pacific Northwest Regional Blood Services, American Red Cross, Portland, OR 97208, USA.
Exp Hematol. 1999 May;27(5):916-27. doi: 10.1016/s0301-472x(99)00020-x.
Studies of murine stem cells suggest that the cytokine receptors Flt3 and c-kit are expressed differentially on the earliest reconstitutional cells, such that Flt3 is not expressed until after stem cell activation. Much less is known about the expression of Flt3 and c-kit on primitive human cells, especially those mobilized into circulation for transplantation. In this study, early circulating precursors were analyzed for expression of Flt3 at the gene and protein levels. Flow cytometric studies showed that >90% of CD34+CD38- cells expressed Flt3 antigen (CD135). The proportion of fresh CD34+ cells expressing Flt3 decreased as CD38 staining increased. These results were confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) analyses, which showed that Flt3 gene expression generally was limited to the CD34+CD38- population. Because Flt3 ligand (FL) enhances the growth and/or maintenance of primitive cells, it was important to know how long early cells retain Flt3 receptor expression in expansion culture. Both RT-PCR analyses and functional tests demonstrated that primitive cells are capable of expressing Flt3 for as long as 2 weeks in liquid medium. During the first week of culture, FL enhanced the generation of cells and progenitors without causing a loss of primitive CD34+CD38-Flt3+ cells. Flt3 expression in cell cultures was limited to precursors retaining a CD34+CD38(-/lo) phenotype. Because the most primitive human precursors are believed to express c-kit at a low level, we examined the FL responsiveness of CD34+CD38-c-kit(-/lo) cells and CD34+CD38-c-kit+ cells. CD34+CD38-c-kit(-/lo), cells constituted a small fraction (12%) of the CD34+CD38- population. Whereas both c-kit(-/lo) and c-kit+ subsets were stimulated by FL, cell expansion (p < 0.01) and colony formation (p < 0.01) were greater and maintained longer with CD34+CD38-c-kit(-/lo) cells. Furthermore, the rapid response to FL suggests that primitive CD34+CD38-c-kit(-/lo) cells express Flt3 at the time of isolation or shortly thereafter. These results demonstrate the presence of Flt3 on CD34+CD38 blood cells and suggests that Flt3 also may be present on a c-kit(-/lo) subset, among the most primitive in circulation. Flt3 is lost during maturation to committed (CD34+CD38+) lineages. Addition of FL to primitive cell cultures stimulates cell expansion while maintaining early CD34+CD38-Flt3+ precursors for at least 7 days. The possible existence of a more primitive CD34+CD38-c-kit(-/lo) Flt3(-/lo) precursor remains to be determined.
对小鼠干细胞的研究表明,细胞因子受体Flt3和c-kit在最早的重建细胞上有差异表达,以至于Flt3直到干细胞激活后才表达。关于Flt3和c-kit在原始人类细胞上的表达,尤其是那些动员进入循环用于移植的细胞,人们了解得要少得多。在本研究中,对早期循环前体细胞进行了Flt3基因和蛋白水平的表达分析。流式细胞术研究显示,>90%的CD34+CD38-细胞表达Flt3抗原(CD135)。随着CD38染色增加,表达Flt3的新鲜CD34+细胞比例下降。逆转录聚合酶链反应(RT-PCR)分析证实了这些结果,该分析显示Flt3基因表达通常仅限于CD34+CD38-群体。由于Flt3配体(FL)可增强原始细胞的生长和/或维持,了解早期细胞在扩增培养中保留Flt3受体表达的时间很重要。RT-PCR分析和功能测试均表明,原始细胞在液体培养基中能够表达Flt3长达2周。在培养的第一周,FL增强了细胞和祖细胞的生成,而不会导致原始CD34+CD38-Flt3+细胞的丢失。细胞培养中的Flt3表达仅限于保留CD34+CD38(-/lo)表型的前体细胞。由于据信最原始的人类前体细胞低水平表达c-kit,我们检测了CD34+CD38-c-kit(-/lo)细胞和CD34+CD38-c-kit+细胞对FL的反应性。CD34+CD38-c-kit(-/lo)细胞占CD34+CD38-群体的一小部分(12%)。虽然c-kit(-/lo)和c-kit+亚群均受到FL刺激,但CD34+CDI38-c-kit(-/lo)细胞的细胞扩增(p<0.01)和集落形成(p<0.01)更大且维持时间更长。此外,对FL的快速反应表明,原始CD34+CD38-c-kit(-/lo)细胞在分离时或此后不久表达Flt3。这些结果证明了CD34+CD38血细胞上存在Flt3,并表明Flt3也可能存在于循环中最原始的c-kit(-/lo)亚群上。Flt3在成熟为定向(CD34+CD38+)谱系的过程中丢失。向原始细胞培养物中添加FL可刺激细胞扩增,同时使早期CD34+CD38-Flt3+前体细胞维持至少7天。更原始的CD34+CD38-c-kit(-/lo)Flt3(-/lo)前体细胞是否存在仍有待确定。